Cambridge Investment Research Advisors, Inc.
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1419186
FAIRFIELD, IA
Position in MDGL
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$858,583
+$47,205 QoQ
Shares Held
1,599
+3.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#208
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $60,632,692 across 72 Biotechnology names. MDGL ranks #19 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,946 | $10,901,236 | |
| 2 | EXEL |
Exelixis, Inc.
|
82,212 | $4,473,154 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,186 | $3,922,344 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
35,157 | $3,056,901 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
15,839 | $2,966,327 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,591 | $2,862,672 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
46,210 | $2,520,293 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
30,727 | $2,288,546 |
All Filings in MDGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $858,583 | 1,599 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $811,378 | 1,550 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $697,643 | 1,198 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $582,956 | 1,271 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $374,668 | 1,238 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $380,252 | 1,148 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $355,164 | 1,151 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $303,262 | 1,429 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $652,492 | 2,329 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $636,623 | 2,384 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,424,606 | 6,157 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,024,324 | 7,014 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,632,708 | 7,068 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,603,761 | 6,620 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,645,540 | 12,560 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $510,171 | 7,850 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $554,745 | 7,750 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $819,302 | 8,350 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $622,839 | 7,350 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $666,246 | 8,350 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $813,373 | 8,350 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,995,508 | 17,060 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,785,390 | 16,060 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $1,859,311 | 15,660 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,762,170 | 15,560 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $992,053 | 14,860 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||